PQ Bypass Appoints Heather Simonsen as Company President
The company also further expands its executive team with key promotions in Operations and Clinical Affairs. MILPITAS, Calif.--(BUSINESS WIRE)--#ClinicalTrial--PQ Bypass,...
Day: October 2, 2020
Adastra Commissions Industrial Scale Cryo-Ethanol System to Triple Capacity
LANGLEY, BC / ACCESSWIRE / October 2, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT: D2EP) ("Adastra") a Health Canada Licensed...
Tree of Knowledge Announces Resumption of Trading and Provides 2020-21 Business Update
TORONTO, ON / ACCESSWIRE / October 2, 2020 / Tree of Knowledge International Inc. (CSE:TOKI) ("TOKI" or the "Company") is...
Celia Morgan, Professor of Psychopharmacology at University of Exeter and Leading Ketamine Investigator, Joins AWAKN Life Sciences
The appointment continues to strengthen AWAKN's industry leading Scientific Advisory Board Toronto, Ontario--(Newsfile Corp. - October 2, 2020) - AWAKN...
LENSAR, Inc. Begins Trading on NASDAQ
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on femtosecond laser surgical...
DECN Receives Significant Initial Order for International GenViro! Saliva Swift Kits for the Detection of COVID-19
First Order From Indian Distributor Is Substantially Larger Than Expected, Exceeding International Launch Expectations With Follow-Up Orders From Distributors in...
ENDRA Life Sciences to Present at the 4th Annual H.C. Wainwright NASH Investor Conference on October 5, 2020
ANN ARBOR, MI / ACCESSWIRE / October 2, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), the pioneer of Thermo...
Jaguar Health’s Mental Health Entheogen Therapeutics Initiative Targets Plant-based Candidate Compound for Possible Schizophrenia and Psychoses Indications
Neuropharmacological profile shows alstonine demonstrates antipsychotic activity and has a mechanism of action distinct from existing therapies SAN FRANCISCO, CA...
Humanigen Announces COVID-19 Case Report Demonstrating Rapid Resolution and Discharge after Single IND Emergency Use Authorization of Lenzilumab(TM)
Case report demonstrated rapid resolution of hypoxemia and mobility and potential benefit of lenzilumab beyond the initial acute hyper-inflammatory window...
Humanigen Announces Lenzilumab in COVID-19 Program Updates
Type B Meeting With FDA Provided Feedback on Emergency Use Authorization Submission Plans Phase 3 Trial Expanded to Brazil With...
Dascena Receives FDA EUA for COVID-19 Hemodynamic Instability and Respiratory Decompensation Prediction System
COViage™ Helps Healthcare Providers with Early Identification of Adult Patients in Need of Ventilation OAKLAND, Calif.--(BUSINESS WIRE)--Dascena, Inc., a machine...
Perimeter Medical Imaging AI Announces Further Update Regarding Second Quarter Financial Statements
TORONTO, CANADA / ACCESSWIRE / October 1, 2020 / Perimeter Medical Imaging AI, Inc. (TSXV:PINK)(FSE:4PC), a medical technology company driven to...